Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study
Clinical trial NCT06390982 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06390982
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-12-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.